129 related articles for article (PubMed ID: 23870855)
1. Rituximab-induced acute severe thrombocytopenia: a case series in patients with mantle cell lymphoma.
Sadashiv SK; Rao R; Fazal S; Lister J
Clin Lymphoma Myeloma Leuk; 2013 Oct; 13(5):602-5. PubMed ID: 23870855
[No Abstract] [Full Text] [Related]
2. Rituximab-induced severe acute thrombocytopenia: a case report and review of literature.
Dhand S; Bahrain H
Cancer Invest; 2008 Nov; 26(9):913-5. PubMed ID: 19034773
[TBL] [Abstract][Full Text] [Related]
3. Cryoglobulins mimicking platelet recovery in a mantle cell lymphoma patient treated with chemoimmunotherapy.
Herishanu Y; Katz BZ
Blood; 2015 Feb; 125(6):1047. PubMed ID: 25802907
[No Abstract] [Full Text] [Related]
4. Rituximab-induced acute severe thrombocytopenia.
Parajuli R; Hire E; Shah BK
Br J Haematol; 2010 Jun; 149(6):804. PubMed ID: 20602622
[No Abstract] [Full Text] [Related]
5. Rituximab-induced acute thrombocytopenia: a report of two cases.
Otrock ZK; Mahfouz RA; Oghlakian GO; Salem ZM; Bazarbachi A
Haematologica; 2005 Nov; 90 Suppl():ECR23. PubMed ID: 16266914
[TBL] [Abstract][Full Text] [Related]
6. Rituximab-associated acute thrombocytopenia: an under-diagnosed phenomenon.
Ram R; Bonstein L; Gafter-Gvili A; Ben-Bassat I; Shpilberg O; Raanani P
Am J Hematol; 2009 Apr; 84(4):247-50. PubMed ID: 19260124
[TBL] [Abstract][Full Text] [Related]
7. Rituximab-induced acute thrombocytopenia: an underappreciated entity.
El-Osta H; Nair B
Leuk Lymphoma; 2013 Dec; 54(12):2736-7. PubMed ID: 23488605
[No Abstract] [Full Text] [Related]
8. [Progressive multifocal leukoencephalopathy after rituximab therapy in a patient with mantle cell lymphoma].
Ota I; Katsura Y; Yoshida C; Yoshizawa K; Ohtani H; Sata T; Komeno T
Rinsho Ketsueki; 2010 Dec; 51(12):1786-8. PubMed ID: 21258190
[TBL] [Abstract][Full Text] [Related]
9. Recurrent mantle cell lymphoma presenting as a solitary rectal mass.
Chittmittraprap S; Intragumtornchai T; Wisedopas N; Rerknimitr R
Endoscopy; 2011; 43 Suppl 2 UCTN():E284-5. PubMed ID: 21915828
[No Abstract] [Full Text] [Related]
10. Rituximab-induced acute thrombocytopenia: a case report and review of the literature.
Yi JH; Kim SJ; Ahn HK; Lee SJ; Chang MH; Kim WS
Med Oncol; 2009; 26(1):45-8. PubMed ID: 18543133
[TBL] [Abstract][Full Text] [Related]
11. Rituximab-induced Acute Thrombocytopenia in a Patient with Follicular Lymphoma: A Case Report and Review of the Literature.
Omura Y; Shimazu H; Takahashi T
Intern Med; 2018 Apr; 57(8):1151-1154. PubMed ID: 29269668
[TBL] [Abstract][Full Text] [Related]
12. Advancing through maintenance in mantle cell lymphoma.
Martin P; Leonard JP
Leuk Lymphoma; 2011 Sep; 52(9):1617-8. PubMed ID: 21699376
[No Abstract] [Full Text] [Related]
13. [Complete response by rituximab monotherapy in a patient with leukemic mantle cell lymphoma diagnosed by fluorescence in situ hybridization analysis].
Okagawa Y; Kuroda H; Ishikawa K; Yamada M; Hoki T; Abe T; Sakurai T; Fujii S; Maeda M; Fujita M; Jyomen W; Iyama S; Kato J
Gan To Kagaku Ryoho; 2012 Oct; 39(10):1547-50. PubMed ID: 23064069
[TBL] [Abstract][Full Text] [Related]
14. Concurrent involved field radiation therapy and temsirolimus in refractory mantle cell lymphoma (MCL).
Kirova YM; Chargari C; Amessis M; Vernant JP; Dhedin N
Am J Hematol; 2010 Nov; 85(11):892. PubMed ID: 20721889
[No Abstract] [Full Text] [Related]
15. Rituximab in the treatment of non-Hodgkin's lymphoma--a critical evaluation of randomized controlled trials.
Griffin MM; Morley N
Expert Opin Biol Ther; 2013 May; 13(5):803-11. PubMed ID: 23560506
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of second rituximab maintenance after relapse in patients with follicular and mantle cell lymphoma.
Sanchez-Gonzalez B; Gimeno E; Garcia-Pallarols F; Ancochea A; Salar A
Leuk Lymphoma; 2014 Oct; 55(10):2384-6. PubMed ID: 24601815
[No Abstract] [Full Text] [Related]
17. Chronic paraneoplastic cutaneous syndrome preceding an indolent variant of mantle cell lymphoma: favorable response to rituximab.
Nemets A; Ronen M; Lugassy G
Acta Haematol; 2006; 115(1-2):113-6. PubMed ID: 16424661
[TBL] [Abstract][Full Text] [Related]
18. Treatment of older patients with mantle-cell lymphoma.
Kluin-Nelemans HC; Hoster E; Hermine O; Walewski J; Trneny M; Geisler CH; Stilgenbauer S; Thieblemont C; Vehling-Kaiser U; Doorduijn JK; Coiffier B; Forstpointner R; Tilly H; Kanz L; Feugier P; Szymczyk M; Hallek M; Kremers S; Lepeu G; Sanhes L; Zijlstra JM; Bouabdallah R; Lugtenburg PJ; Macro M; Pfreundschuh M; Procházka V; Di Raimondo F; Ribrag V; Uppenkamp M; André M; Klapper W; Hiddemann W; Unterhalt M; Dreyling MH
N Engl J Med; 2012 Aug; 367(6):520-31. PubMed ID: 22873532
[TBL] [Abstract][Full Text] [Related]
19. Rituximab-induced severe acute thrombocytopenia in a patient with splenic marginal zone lymphoma.
Kars TU; Yorgancı ZF; Yaşkıran O; Tekinalp A; Demircioğlu S
J Oncol Pharm Pract; 2023 Jun; 29(4):1011-1014. PubMed ID: 36458320
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of vincristine sulfate liposome injection (Marqibo) and rituximab for patients with relapsed and refractory diffuse large B-Cell lymphoma or mantle cell lymphoma in need of palliative therapy.
Kaplan LD; Deitcher SR; Silverman JA; Morgan G
Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):37-42. PubMed ID: 24252360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
